About

Dr. Steven Schulz is a pioneering breast surgeon whose research focuses on advancing surgical techniques for breast cancer treatment, particularly through the innovative application of robotic technology. His major contributions center on the refinement and validation of robot-assisted nipple-sparing mastectomy (RNSM), a minimally invasive procedure designed to improve both oncologic outcomes and patient quality of life. His most cited work, a 2020 study on residual breast tissue after RNSM (20 citations), critically evaluates the completeness of glandular excision as a surrogate for oncologic safety, addressing a key concern in this emerging technique. Dr. Schulz further demonstrated his leadership by authoring a 2021 prospective pilot study protocol (13 citations) that systematically assesses the safety and feasibility of RNSM, laying the groundwork for broader clinical adoption. By tackling the ergonomic challenges of traditional open surgery and providing rigorous, evidence-based protocols, Dr. Schulz is shaping the future of breast conservation surgery, offering patients a less invasive option without compromising oncologic principles. His work is essential reading for surgeons and researchers exploring the intersection of robotics and breast oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
33
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Residual breast tissue after robot-assisted nipple sparing mastectomy
20 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago